🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In people (n=35173) with newly dx #osteoarthritis: 27% used oral NSAIDs 10% used opioids 57% attended #physiotherapy What about those with contraindications to oral NSAIDs? Read in DEC's Osteoarthritis and Cartilage Journals from Tuhina Neogi, MD, PhD Andrea Dell'isola Martin Englund tinyurl.com/4nt852pc

Does Abatacept work in Myositis! See results of phase 3 RCT on Abatacept efficacy and safety in Myositis. Safe and well tolerated. Efficacy in Necrotizing Myositis and Anti-Synthetase; not in DM. High placebo rates continues to be a problem in trials.

Met Sarah Gebauer, MD, MSPH she/her #blm today NIAMS Grants and Funding K forum — check out this podcast to learn about cutting edge application of geocoding research application to improving opportunities for physical activity among people with knee #osteoarthritis

Upgrade your #causalinference arsenal. A revision of our book "Causal Inference: What If" is available at miguelhernan.org/whatifbook Thanks to everyone who suggested improvements, reported typos, and proposed new citations and material. Enjoy the #WhatIfBook. Also, it's free.

Spotted yesterday in its native habitat and original form prior to its metamorphosis into a sewing kit:

Holiday presents came early when I received my copies of the 12th Edition of Firestein&Kelley’s Textbook of #Rheumatology. So cool to see my name on the cover as one of the editors!! Here’s a 20% off code for use on ElsevierHealth’s website: BAFF20 #FiresteinKelleyRheum12

Join us for the first C-COMP seminar of 2025, Jan 16 8 am CST. Dr. Luana Colloca will discuss placebo effects in osteoarthritis! Please register to attend virtually - or come to Chicago for the live experience.

Great to see the 12th edition of Elsevier Firestein & Kelley's Textbook of Rheumatology! It was wonderful to have contributed again to updated evidence-based guidance for management of knee osteoarthritis. #rheumatology #osteoarthritis #chronicpain

For those who cannot access the New York Times, here a short summary of the outstanding article on #ChronicPain with contributions from Rob Gereau and other great colleagues. michelecuratolomd.com/news/the-new-y…

Call for applications for the 2025 ACR/EULAR Research Exchange Program! Junior academic #rheums & #rheum professionals are encouraged to apply for this opportunity to exchange knowledge with colleagues abroad. Apply by Feb. 14. Details → acr.tw/3SCQpAL

Our next #methodologyjournal club is Wednesday, February 5th at 12:15pm ET 🎙️Gillian Fennell will be presenting and Dan Riddle will be the guest discussant 📅Registration link: bostonu.zoom.us/meeting/regist… 🔗Paper link: journals.lww.com/jbjsjournal/fu…

Our next #methodologyjournal club is Wednesday, February 5th at 12:15pm ET 🎙️Gillian Fennell will be presenting and Dan Riddle will be the guest discussant 📅Registration link: bostonu.zoom.us/meeting/regist… 🔗Paper link: journals.lww.com/jbjsjournal/fu…

FDA has approved Journavx (suzetrigine) 50 mg tablets, 1st in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals

We are thrilled to celebrate our esteemed BU/BMC rheumatology providers who have been recognized as Boston Magazine’s Top Doctors for 2025! Their dedication, expertise, and compassionate care continue to make a profound impact on the lives of their patients.

#DYK there are a variety of cardiovascular drugs that can impact serum urate levels? In a recent blog, Dr. Tuhina Neogi shares intricate connections between gout and comorbidities, specifically heart conditions. Read more today: bit.ly/3Y3VPYh

FDA has approved Journavx (suzetrigine) 50 mg tablets, 1st in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals

This is not going to make or keep America great. It will put the US behind other countries: Trump’s NIH challenges the model that underlies U.S. scientific dominance - The Washington Post apple.news/AmHOhTuW3QR2ND…

Happy Valentines Day